Page 217 - Pagetit
P. 217

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   Fryer JD, Lukas RJ (1999) Noncompetitive functional inhibition at diverse, human
                   nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and
                   ibogaine. Journal of Pharmacology and Experimental Therapeutics, 288:88–92.
                   Fu Y et al. (2000) Systemic nicotine stimulates dopamine release in nucleus
                   accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the
                   ventral tegmental area. Journal of Pharmacology and Experimental Therapeutics,
                   294:458–465.
                   Funahashi S, Kubota K (1994) Working memory and prefrontal cortex.
                   Neuroscience Research, 21:1–11.
                   Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric
                   diagnosis in cocaine abusers: clinical observations. Archives of General Psychiatry,
                   43:107–113.
                   George TP et al. (1995) Effects of clozapine on smoking in chronic schizophrenic
                   outpatients. Journal of Clinical Psychiatry, 56:344–346.
                   George TP et al. (2000) Nicotine transdermal patch and atypical antipsychotic
                   medications for smoking cessation in schizophrenia. American Journal of
                   Psychiatry, 157:1835–1842.
                   George TP et al. (2002) Effects of smoking abstinence on visuospatial working
                   memory function in schizophrenia. Neuropsychopharmacology, 26:75–85.
                   Gerding LB et al. (1999) Alcohol dependence and hospitalization in schizophrenia.
                   Schizophrenia Research, 38:71–75.
                   Geyer MA, Markou A (1995) Animal models of psychiatric disorders. In: Bloom
                   FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New
                   York, NY, Raven Press:787–798.
                   Geyer MA, Markou A (2002) The role of preclinical models in the development of
                   psychotropic drugs. In: Charney D et al., eds. Psychopharmacology: the fifth
                   generation of progress. Hagerstown, MD: Lippincott, Williams & Wilkins:445–455.
                   Gheorvassaki EG et al. (1992) Effects of acute and chronic desipramine treatment
                   on somatostatin receptors in brain. Psychopharmacology, 108:363–366.
                   Gioanni Y et al. (1999) Nicotinic receptors in the rat prefrontal cortex: increase in
                   glutamate release and facilitation of mediodorsal thalamo-cortical transmission.
                   European Journal of Neuroscience, 11:18–30.
                   Glassman AH (1993) Cigarette smoking: implications for psychiatric illness.
                   American Journal of Psychiatry, 150:546–553.
                   Glassman AH et al. (1988) Heavy smokers, smoking cessation, and clonidine:
                   results of a double-blind, randomized trial. Journal of the American Medical
                   Association, 259:2863–2866.
                   Glassman AH et al. (1990) Smoking, smoking cessation, and major depression.
                   Journal of the American Medical Association, 264:1546–1549.
                   Glynn SM, Sussman S (1990) Why patients smoke. Hospital and Community
                   Psychiatry, 41:1027–1028.
                   Goeders NE, Bienvenu OJ, de Souza EB (1990) Chronic cocaine administration
                   alters corticotropin-releasing factor receptors in the rat brain. Brain Research,
                   531:322–328.


                                                  196




          Chapter_6                196                             19.1.2004, 11:49
   212   213   214   215   216   217   218   219   220   221   222